Gastroduodenal Injury After Radioembolization of Hepatic Tumors

  title={Gastroduodenal Injury After Radioembolization of Hepatic Tumors},
  author={Cristina Carretero and Miguel A Mu{\~n}oz-Navas and Maite Bet{\'e}s and Ram{\'o}n Ang{\'o}s and Jos{\'e} Carlos S{\'u}btil and Ignacio Fern{\'a}ndez-Uri{\'e}n and Susana de la Riva and Josu Sola and Jos{\'e} Ignacio Bilbao and Esther de Luis and Bruno Sangro},
  journal={The American Journal of Gastroenterology},
BACKGROUND:Radioembolization is a new tool for the treatment of hepatic tumors that consists in the injection of biocompatible microspheres carrying radioisotopes into the hepatic artery or its branches.METHODS:We have performed radioembolization in 78 patients with hepatic tumors using resin-based microspheres loaded with yttrium-90. All patients were previously evaluated to minimize the risk of hazardous irradiation to nontarget organs and to obtain the data needed for dose calculation… 
Radioembolization: Concepts and Procedures
Radioembolization (RE) is a form of intravascular brachytherapy that consists in delivering implantable radioactive microspheres into the arteries that feed liver tumors in order to provide a high
Radioembolization for hepatocellular carcinoma.
Biocompatibility, Inflammatory Response, and Recannalization Characteristics of Nonradioactive Resin Microspheres: Histological Findings
In conclusion, resin microspheres (15–30 μm diameter) trigger virtually no inflammatory response in target tissues (liver and kidney) and are associated with a mild to moderate perivascular inflammatory reaction.
Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
A comprehensive review was carried out analyzing both the best selection criteria of patients who really benefit from TARE and the new advances of this therapy which add significant value to the therapeutic weaponry against HCC.
Radioembolization of hepatic tumors.
  • A. Kennedy
  • Medicine
    Journal of gastrointestinal oncology
  • 2014
A wealth of experience using RE in solid tumors exists and ongoing major prospective clinical trials will soon clarify the role of RE in the management of metastatic colorectal liver metastases, as this beneficial and now widely available therapy is being increasingly incorporated into the standard therapy algorithms of multidisciplinary GI cancer teams worldwide.
Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors.
The routine use of SPECT has decreased the incidence of gastrointestinal lesions due to unintended deployment of ⁹⁰Y particles, and all patients were free from severe symptoms at the end of follow-up.
Yttrium-90 microsphere induced gastrointestinal tract ulceration
Gastrointestinal ulceration is a known yet rarely reported complication of 90Y microsphere embolization with potentially life-threatening consequences and once diagnosed, refractory ulcers should be considered for aggressive surgical management.
Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review.
Two currently available radioembolic devices (90Y, 188Rh) are highlighted and the reader is provided with a recent review of the literature to highlight two currently available Radioembolization therapies for patients with unresectable HCC.
Radioembolization of liver tumors with yttrium-90 microspheres.
Radioembolization (RE), also termed selective internal radiation therapy (SIRT), has been gradually introduced to the clinical arsenal of cytoreductive modalities in recent years. There is growing


Right Gastric Artery Embolization Prior to Treatment with Yttrium-90 Microspheres
RGA embolization can help minimize the gastroduodenal deposition of radioactive particles in patients presenting with primary or metastatic liver tumors and should routinely be carried out.
Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
Late effects of radiation therapy on the gastrointestinal tract.
Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: emphasis on the role of exploratory laparotomy and fractionation.
Severe radiation injuries of the stomach, small intestine, colon and rectum.
Several examples have been presented from the experience to illustrate the clinical pattern, life history and surgical management of complications of radiation therapy for abdomino-pelvic cancer.
Effect of X-irradiation on the stomach of the rat.
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy
In patients with metastatic colorectal cancer that have previously received treatment with 5-FU based chemotherapy, treatment with SIR-spheres has demonstrated encouraging activity, and further studies are required to better define the subsets of patients most likely to respond.
Acute gastric ulcers induced by radiation.
(1966). Acute Gastric Ulcers Induced by Radiation. Acta Radiologica: Therapy, Physics, Biology: Vol. 4, No. 4, pp. 289-297.
Radioembolization using Y90-resin microspheres for patients with advanced hepatocellular carcinoma
  • Int J Radiat Oncol Biol Phys 2006;66:792–800
  • 2006
Quimioterapia regional